What is the effect of adding teriparatide or abaloparatide to alendronate therapy in patients with osteoporosis?

Evidence from high-quality studies demonstrates that sequential therapy with abaloparatide or teriparatide followed by alendronate increases bone density and reduces fracture risk in patients with osteoporosis, compared to placebo followed by alendronate.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24172956
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What is the effect of adding teriparatide or abaloparatide to alendronate therapy in patients with osteoporosis?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Bone health and osteoporosis research
article

What is the effect of adding teriparatide or abaloparatide to alendronate therapy in patients with osteoporosis?

Tripdatabase
article en

Abstract

Evidence from high-quality studies demonstrates that sequential therapy with abaloparatide or teriparatide followed by alendronate increases bone density and reduces fracture risk in patients with osteoporosis, compared to placebo followed by alendronate.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon